ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "COVID-19"

  • Abstract Number: 0614 • ACR Convergence 2020

    Impact of COVID-19 Pandemic on the Rheumatology Practice in Mexico: Mexican College of Rheumatology Survey

    Natllely Ruiz1, José Enrique Ruiz Guizar2, Erick A Zamora Tehozol3, Iris Jazmín Colunga Pedraza4, Cristina Hernández-Díaz5, Vijaya Rivera-Terán6, Cesar Pacheco Tena7 and Deshire Alpizar-Rodriguez6, 1Instituto Nacional de Enfermedades Respiratorias, Mexico City, Distrito Federal, Mexico, 2Independent, Mexico City, Distrito Federal, Mexico, 3Centro Médico Pensiones, Merida, Yucatan, Mexico, 4Rheumatology service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Mexico, 5Instituto Nacional de Rehabilitación, Mexico City, Distrito Federal, Mexico, 6Colegio Mexicano de Reumatología, Mexico City, Distrito Federal, Mexico, 7Universidad Autonoma de Chihuahua, Chihuahua, Chihuahua, Mexico

    Background/Purpose: COVID-19 pandemic is an evident challenge for healthcare systems and daily clinical practice in developing countries. Particularly, chronic diseases attention has faced difficulties. The…
  • Abstract Number: 0984 • ACR Convergence 2020

    Neighborhood Deprivation and Race/Ethnicity Affects COVID-19 Risk and Severity in SLE

    Ashira Blazer1, Ruth Fernandez-Ruiz2, Mala Masson2, Rebecca Haberman3, Rochelle Castillo4, Jose Scher4, Huda Algasas5, Allison Guttmann2, Philip Carliucci3, Kristina Deonaraine2, Michael Golpanian6, Kimberly Robins2, Miao Chang2, H. Michael Belmont6, Jill Buyon7, Amit Saxena3 and Peter Izmirly6, 1NYU School of Medicine, New York, NY, 2New York University School of Medicine, New York, 3NEW YORK UNIVERSITY SCHOOL OF MEDICINE, New York, NY, 4NYU School of Medicine, New York City, 5Columbia University, New York, NY, 6New York University, New York, NY, 7Department of Medicine, NYU School of Medicine, New York, NY

    Background/Purpose: Disparities have been reported during the coronavirus disease (COVID-19) outbreak. Systemic lupus erythematosus (SLE) patients represent a unique group that is affected by clinical,…
  • Abstract Number: 1497 • ACR Convergence 2020

    COVID-19 in Pregnant Patients with Rheumatic Disease: Data from the COVID-19 Global Rheumatology Alliance

    Bonnie Bermas1, Megan Clowse2, Milena Gianfrancesco3, Jonathan Hausmann4, Pedro M Machado5, Emily Sirotich6, Helen Robinson7, Anja Strangfeld8, Jinoos Yazdany9 and Philip Robinson10, 1UTSouthwestern.edu, Dallas, TX, 2Duke University, Chapel Hill, NC, 3University of California, San Francisco, San Francisco, CA, 4Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA, 5University College London, London, United Kingdom, 6McMaster University, Hamilton, ON, Canada, 7University of Queensland School of Medicine, HERSTON, Queensland, Australia, 8German Rheumatism Research Center, Berlin, Germany, 9UCSF, San Francisco, CA, 10University of Queensland, Herston, Queensland, Australia

    Background/Purpose: The impact of COVID-19 on pregnancy in patients with rheumatic disease is unknown. We describe COVID-19 outcomes in pregnant rheumatic disease patients reported to…
  • Abstract Number: 0008 • ACR Convergence 2020

    COVID-19 Infection Among Patients with Rheumatic Disease on Biologic & Targeted Therapies: A Systematic Review

    Akhil Sood1, Arbi Galestanian1, Vijaya Murthy2, Emilio Gonzalez1 and Mukaila Raji1, 1University of Texas Medical Branch, Galveston, TX, 2University of Texas Medical Branch, League City, TX

    Background/Purpose: Information about the outcomes of patients with rheumatic disease with SARS-CoV-2 infection is scarce. Patients with rheumatic disease on immunosuppressive medications might represent a…
  • Abstract Number: 0069 • ACR Convergence 2020

    Identification of CD13 as a Potential Cause for SARS-CoV-2-triggered Hyperinflammation and Thrombosis

    Eliza Pei-Suen Tsou1, Gautam Sule1, Mikel Gurrea Rubio2, M. Asif Amin1, Yu Zuo1, Jason Knight1, Yogendra Kanthi3 and David Fox1, 1Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2Division of Rheumatology, University of Michigan, Canton, MI, 3Division of Cardiovascular Medicine, Ann Arbor

    Background/Purpose: The ectopeptidase CD13, which is highly expressed on stromal and myeloid cells in joints, lung and other tissues, is a known receptor for many…
  • Abstract Number: 0468 • ACR Convergence 2020

    Concerns and Health-Related Behaviors During the COVID-19 Pandemic in Patients with or Without Autoimmune Rheumatic Disease in a Large Physician Network

    Michael George1, Shilpa Venkatachalam2, Shubhasree Banerjee1, Joshua Baker1, Peter Merkel1, David Curtis3, Kelly Gavigan4, Maria (Maio) Danila5, Daniel Kirby6, George Munoz7, William Sunshine8, William Nowell9 and Jeffrey R Curtis10, 1University of Pennsylvania, Philadelphia, PA, 2Global Healthy Living Foundation, Upper Nyack, 3Global Healthy Living Foundation, New York City, 4Global Healthy Living Foundation, Upper Nyack, NY, 5University of Alabama at Birmingham (UAB), Birmingham, AL, 6AARA, Charlotte, NC, 7AARA, Aventura, FL, 8AARA, Boca Raton, FL, 9Global Healthy Living Foundation, New York City, NY, 10Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Patients with autoimmune rheumatic diseases (ARD) may be particularly concerned about COVID-19. We aimed to compare concerns and health-related behaviors of patients with common…
  • Abstract Number: 0623 • ACR Convergence 2020

    Cytokine Storm: Outcomes in SARS-CoV-2 Patients Treated with Biologics in a Rheumatology Cohort

    Neha Chiruvolu1, Muntarin Karim2, Patil Injean3, Sandy Lee3, Karina Torralba4, Christina Downey3, Mehrnaz Hojjati5, Loomee Doo5, Donna Jose6, Deepa Panikkath3, Micah Yu5, Anna Lafian5, Marven Cabling5 and Vaneet Sandhu7, 1UC Riverside School of Medicine, Riverside, CA, 2Loma Linda University Health System, Loma Linda, CA, 3Loma Linda University Medical Center, Redlands, CA, 4Loma Linda University School of Medicine, Redlands, CA, 5Loma Linda University Medical Center, Loma Linda, CA, 6Loma Linda University Medical Center, Ontario, CA, 7Loma Linda University, Loma Linda, CA

    Background/Purpose: Cytokine Release Syndrome (CRS) or Macrophage Activation Syndrome (MAS) is a life threating hyperinflammatory condition that can complicate rheumatic disease as well as infections…
  • Abstract Number: 1140 • ACR Convergence 2020

    How Did SARS-CoV2/COVID-19 Pandemic Affected Patients with Rheumatic Diseases in Latin America? A Regional Survey from PANLAR

    Daniel Fernández-Ávila1, Julián Barahona-Correa1, Diana Romero-Alvernia1, Sergio Kowalski2, Ana María Sapag Durán3, Antonio Cachafeiro Vilar4, Belia Lucía Meléndez Muñoz5, Carlos Santiago Pastelín6, Claudia Ramírez7, Daniel Palleiro Rivero8, Diego Alejandro Jaimes9, Dina María Arrieta10, Guillermo Pons-Estel11, Jossiell Then Báez12, Manuel Ugarte-Gil13, Mario Cardiel14, Nelly Colman15, Nilmo Chávez Pérez16, Paula Burgos17, Rubén Montufar18, Sayonara Sandino19, Yurilis Fuentes-Silva20 and Enrique Soriano21, 1Pontificia Universidad Javeriana - Hospital Universitario San Ignacio, Bogota, Colombia, 2Unidad de Investigación PANLAR. Universidade Federal do Paraná, Paraná, Brazil, 3Hospital Universitario Japonés, Santa Cruz, Bolivia, 4Pacífica Salud - Hospital Punta Pacífica,, Ciudad de Panamá, Panama, 5Hospital de la Policía Nacional N1 Quito, Quito, Ecuador, 6Instituto Hondureño de la Seguridad Social, Tegucigalpa, Honduras, 7Organización Keralty, Bogota, 8Instituto Nacional de Reumatología del Uruguay - Universidad de la República, Montevideo, Uruguay, 9Clínicos IPS- Universidad de la Sabana, Bogotá D.C., Colombia, 10Hospital México, San José de Costa Rica, Costa Rica, 11Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina, 12Hospital Metropolitano de Santiago (HOMS), Santiago, Dominican Republic, 13Servicio de Reumatología. Hospital Nacional Guillermo Almenara Irigoyen and Universidad Científica del Sur, Lima, Peru, 14Centro de Investigación Clínica de Morelia, Morelia, Mexico, 15Hospital de Clínicas - Universidad Nacional de Asunción, Asunción, Paraguay, 16Instituto Guatemalteco de Seguridad Social, Ciudad de Guatemala, Guatemala, 17Universidad Católica de Chile, Santiago de Chile, Chile, 18Consultorio de Especialidades del Instituto Salvadoreño del Seguro Social, San Salvador, El Salvador, 19Policlínica Nicaragüense, Managua, Nicaragua, 20Centro Clínico Universitario de Oriente - Universidad de Oriente, Ciudad Bolivar, Venezuela, 21Department of Public Health, Instituto Universitario, Escuela de Medicina Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Capital Federal, Buenos Aires, Argentina

    Background/Purpose: Social isolation during SARS-CoV-2/COVID-19 pandemic has undermined follow-up of patients with rheumatic diseases. These patients face a critical dilemma between the risk of exposure…
  • Abstract Number: 1576 • ACR Convergence 2020

    Acute Respiratory Viral Adverse Events During Use of Antirheumatic Disease Therapies: A Scoping Review

    Adam Kilian1, Yu Pei Eugenia Chock2, Irvin Huang3, Elizabeth Graef4, Laura Upton5, Aneka Khilnani6, Sonia Silinsky Krupnikova7, Ibrahim Almaghlouth8, Laura Cappelli9, Ruth Fernandez-Ruiz10, Brittany Frankel3, Jourdan Frankovich11, Carly Harrison12, Bharat Kumar13, Kanika Monga14, Jorge Rosario Vega11, Namrata Singh15, Jeffrey Sparks16, Elaine Sullo6, Kristen Young17, Ali Duarte-Garcia18, Michael Putman19, Sindhu Johnson20, Jean Liew3 and Aruni Jayatilleke21, 1George Washington University, Washington, DC, 2Yale School of Medicine, Greenwich, CT, 3University of Washington, Seattle, WA, 4Beth Israel Deaconess Medical Center, Boston, MA, 5Georgetown University School of Medicine, Washington, DC, 6The George Washington University School of Medicine and Health Sciences, Washington, DC, 7The George Washington University School of Medicine and Health Sciences, Rockville, MD, 8King Saud University, Riyadh, Saudi Arabia, 9Johns Hopkins School of Medicine, Baltimore, MD, 10New York University School of Medicine, New York, 11Temple University, Philadelphia, PA, 12Lupus Chat, NA, 13University of Iowa Hospitals and Clinics, Iowa City, IA, 14UT Health Rheumatology, HOUSTON, TX, 15University of Washington, Bellevue, WA, 16Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 17University of Texas Southwestern Medical Center, Dallas, TX, 18Mayo Clinic, Rochester, MN, 19Northwestern University, Chicago, IL, 20University of Toronto, Toronto, ON, Canada, 21Section of Rheumatology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA

    Background/Purpose: COVID-19 threatens the health of people worldwide, although it remains unclear to what extent antirheumatic disease therapies increase susceptibility to complications of viral respiratory…
  • Abstract Number: 0009 • ACR Convergence 2020

    Prevalence of Hydroxychloroquine and Chloroquine Side Effects in Rheumatology Patients: A Retrospective Survey of 115 Cases

    Zakaria El Ouali1, Elie Bassa1, Abdoul-Rahamane Halidou Idrissa1, Sarah Tazi1, Samy Housbane2, Mohamed Bennani Othmani2, Kawtar Nassar1 and Saadia Janani1, 1Department of Rheumatology, University Hospital of Ibn Rochd, Casablanca, Morocco, Casablanca, Grand Casablanca, Morocco, 2Medical Informatics Laboratory, Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco, Casablanca, Grand Casablanca, Morocco

    Background/Purpose: Antimalarial drugs (ADs), including chloroquine (CQ) and hydroxychloroquine (HCQ), have anti-inflammatory, immunomodulatory, antiparasitic, anti-thrombotic, and antiviral properties. Their indications in rheumatology have been known…
  • Abstract Number: 0079 • ACR Convergence 2020

    Analysis of COVID-19 and Rheumatology Twitter Activity During the Pandemic Months

    Mosaab Mohameden1 and Ali H.Ali2, 1University of Cincinnati College of Medicine, Cincinnati, OH, 2University of California San Francisco Fresno, Fresno, CA

    Background/Purpose: Twitter is a popular social media platform that is widely used to publish information and exchange ideas. There are over 300 million active monthly…
  • Abstract Number: 0475 • ACR Convergence 2020

    To Attend or Note to Attend; The Medical Student’s Dilemma

    Benjamin Widener1, Amy Cannella1 and Sarah McBrien1, 1University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: We present a comparison of student’s outcomes with remote video-based learning versus lecture attendance in pre-clinical medical students during a musculoskeletal curriculum, thus allowing…
  • Abstract Number: 0626 • ACR Convergence 2020

    Early Rise in CRP Is Associated with Progression to Respiratory Failure and Intubation in COVID-19 Patients

    Alisa Mueller1, Tomoyoshi Tamura2, Julia Jezmir3, Erin Penn1, Gregory Keras4, Anthony Massaro5 and Edy Kim5, 1Brigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity, Boston, MA, 2Brigham and Women's Hospital, Division of Pulmonary and Critical Care Medicine, Boston, MA, 3Brigham and Women’s Hospital, Department of Medicine, Boston, MA, 4Brigham and Women’s Hospital, Division of Rheumatology, Inflammation, and Immunity, Boston, MA, 5Brigham and Women’s Hospital, Division of Pulmonary and Critical Care Medicine, Boston, MA

    Background/Purpose: During the course of hospitalization, it is often unclear which COVID-19 patients will progress from non-critical to critical illness. Timely identification of these patients…
  • Abstract Number: 1141 • ACR Convergence 2020

    Reversing Seasonal Decline of T2T Outcome in RA Patients Under Double Hits by Chinese New Year and COVID-19 Epidemic via Online Interaction with SSDM

    Rong Mu1, Hongbin Li2, Zhanyun Da3, Anbin Huang4, Hongzhi Wang5, Jing Lu6, Jianhong Wu7, Shengtao Zhang8, Yikai Yu9, Chun Li10, Shouxin Li9, Peng Ji11, Hua Wei12, Bin Wu13, Zhenbin Li14, Lingxun Shen15, Yanping Zhao16, Yi Zhao17, Xiaoqiang Hou18, Hui Xiao19, Yuhua Jia20, Bing Wu20, Yonggang Zhao20, Xin Chen19, Miaomiao Song20, Fei Xiao20 and Zhanguo Li21, 1People's Hospital, Beijing University Medical School, Beijing, Beijing, China (People's Republic), 2The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China (People's Republic), 3The affiliated Hospital of Nantong University, Nantong, Jiangsu, China (People's Republic), 4Union Hospital Affiliated Tongji Medical College of Huazhong University of Science and Technology, WuHan, China (People's Republic), 5The First Hospital of Jiaxing, Jiaxing, China (People's Republic), 6First Affiliated Hospital of China Medical University, Shenyang, China (People's Republic), 7Department of Rheumatology, Dazhou Central Hospital, Dazhou, China (People's Republic), 8Tongji Hospital Affiliated Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China (People's Republic), 9Tongji Hospital Affiliated to Tongji Medical College of HUST, Wuhan, Hubei, China (People's Republic), 10People's Hospital, Beijing University Medical School, beijing, China (People's Republic), 11The first affiliated hospital of xinjiang medical university, Urumqi, Xinjiang, China (People's Republic), 12Northern Jiangsu People's Hospital, Yangzhou, China (People's Republic), 13Chongqing Hospital of Traditional Chinese Medicine, chongqing, China (People's Republic), 14Chinese people ’s liberation army joint service support force 980 hospital, shijiazhuang, Jiangxi, China (People's Republic), 15Union Hospital Affiliated Tongji Medical College of HUST, Wuhan, Hubei, China (People's Republic), 16First Affiliated Hospital of Harbin Medical University, Harbin, China (People's Republic), 17Xuanwu Hospital, Capital Medical University, Beijing, China, Beijing, China (People's Republic), 18Yichang Central People's Hospital, Beijing, China (People's Republic), 19Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), 20Shanghai Gothic Internet Technology Co., Ltd., Shanghai, China (People's Republic), 21Peking University People’s Hospital, Xicheng, Beijing, China (People's Republic)

    Background/Purpose: Treat-to-target (T2T), achieving a DAS28 below 3.2 is the main management strategy for RA. The Chinese New Year is a long holiday started in…
  • Abstract Number: 1583 • ACR Convergence 2020

    Impact of Telehealth Implementation on Practice Patterns and Electronic Health Record Utilization During COVID19

    Mithu Maheswaranathan1, Philip Chu1, Andrew Johannemann1, Megan Clowse2, Lisa Criscione-Schreiber3 and David Leverenz1, 1Duke University, Durham, NC, 2Duke University, Chapel Hill, NC, 3Duke University School of Medicine, Durham, NC

    Background/Purpose: The COVID19 pandemic necessitated practice changes throughout health systems worldwide.  Our academic rheumatology practice rapidly adopted telehealth (telephone or video visits), with unknown consequences…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 38
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology